Correia Maria João, Pimpão António B, Lopes-Coelho Filipa, Sequeira Catarina O, Coelho Nuno R, Gonçalves-Dias Clara, Barouki Robert, Coumoul Xavier, Serpa Jacinta, Morello Judit, Monteiro Emília C, Pereira Sofia A
CEDOC, NOVA Medical School, Universidade Nova de Lisboa, 1169-056 Lisboa, Portugal.
Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), Rua Prof Lima Basto, 1099-023 Lisboa, Portugal.
Antioxidants (Basel). 2021 Sep 17;10(9):1484. doi: 10.3390/antiox10091484.
We hypothesized that an interplay between aryl hydrocarbon receptor (AhR) and cysteine-related thiolome at the kidney cortex underlies the mechanisms of (mal)adaptation to chronic intermittent hypoxia (CIH), promoting arterial hypertension (HTN). Using a rat model of CIH-HTN, we investigated the impact of short-term (1 and 7 days), mid-term (14 and 21 days, pre-HTN), and long-term intermittent hypoxia (IH) (up to 60 days, established HTN) on CYP1A1 protein level (a sensitive hallmark of AhR activation) and cysteine-related thiol pools. We found that acute and chronic IH had opposite effects on CYP1A1 and the thiolome. While short-term IH decreased CYP1A1 and increased protein--thiolation, long-term IH increased CYP1A1 and free oxidized cysteine. In addition, an in vitro administration of cystine, but not cysteine, to human endothelial cells increased expression, supporting cystine as a putative AhR activator. This study supports CYP1A1 as a biomarker of obstructive sleep apnea (OSA) severity and oxidized pools of cysteine as risk indicator of OSA-HTN. This work contributes to a better understanding of the mechanisms underlying the phenotype of OSA-HTN, mimicked by this model, which is in line with precision medicine challenges in OSA.
我们推测,肾皮质中芳烃受体(AhR)与半胱氨酸相关硫醇之间的相互作用是慢性间歇性缺氧(CIH)(不良)适应机制的基础,会促进动脉高血压(HTN)。使用CIH-HTN大鼠模型,我们研究了短期(1天和7天)、中期(14天和21天,高血压前期)和长期间歇性缺氧(IH)(长达60天,已确诊高血压)对CYP1A1蛋白水平(AhR激活的敏感标志)和半胱氨酸相关硫醇池的影响。我们发现,急性和慢性IH对CYP1A1和硫醇有相反的影响。短期IH会降低CYP1A1并增加蛋白质硫醇化,而长期IH会增加CYP1A1和游离氧化型半胱氨酸。此外,体外向人内皮细胞施用胱氨酸而非半胱氨酸会增加[相关蛋白]表达,支持胱氨酸作为假定的AhR激活剂。本研究支持CYP1A1作为阻塞性睡眠呼吸暂停(OSA)严重程度的生物标志物,以及氧化型半胱氨酸池作为OSA-HTN的风险指标。这项工作有助于更好地理解该模型模拟的OSA-HTN表型的潜在机制,这与OSA的精准医学挑战相一致。